SDRL - Minutes from the Annual General Meeting 2014

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
SDRL - Minutes from the Annual General Meeting 2014

HAMILTON, Bermuda, Sept. 19, 2014 (GLOBE NEWSWIRE) -- Seadrill Limited (the "Company") advises that the 2014 Annual General Meeting of the Company was held on September 19, 2014 at 9:00 a.m. at the Elbow Beach Hotel, 60 South Shore Road, Paget PG04, Bermuda.  The audited consolidated financial statements for the Company for the year ended December 31, 2013 were presented to the Meeting.

Immediately prior to commencement of the Meeting, Mr. Tor Olav Trøim withdrew his nomination and therefore the proposal to re-elect him as a Director of the Company was not considered.

The following resolutions were passed:

1)      To re-elect John Fredriksen as a Director of the Company. 

2)      To re-elect Kate Blankenship as a Director of the Company.

3)      To re-elect Katherine Fredriksen as a Director of the Company.

4)      To re-elect Carl Erik Steen as a Director of the Company.

5)   To re-elect Bert Bekker as a Director of the Company.

6)   To re-elect Paul Leand, Jr., as a Director of the Company.

7)   To re-appoint PricewaterhouseCoopers LLP as auditors and to authorise the Directors to determine their remuneration.

8)   That the remuneration payable to the Company's Board of Directors of a total amount of fees not to exceed US$1,500,000 be approved for the year ended December 31, 2014.

Hamilton, Bermuda

September 19, 2014

This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

HUG#1857190

Seadrill +47 51 30 99 00

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Zenas BioPharma Investors Urged to Join Class Action Lawsuit

Updated Category News Views 119

Overview of the Class Action Lawsuit Levi & Korsinsky, LLP is reaching out to investors in Zenas BioPharma, Inc. regarding a crucial class action lawsuit. This lawsuit may greatly impact those who have invested in Zenas BioPharma as it seeks to compensate individuals who have suffered losses due to alleged securities fraud. Understanding the Legal Landscape This class...

Continue Reading
Ayar Labs Raises $155 Million to Transform AI Infrastructure

Updated Category News Views 716

Ayar Labs Secures Significant Funding to Enhance AI Infrastructure Ayar Labs has recently secured $155 million in financing aimed at addressing the critical needs in AI infrastructure. With backing from prominent investors such as AMD Ventures, Intel Capital, and NVIDIA, alongside Advent Global Opportunities and Light Street Capital, this investment elevates the total...

Continue Reading
Transforming the Non-Profit Sector: The Impact Collaborative

Updated Category News Views 159

Impact Collaborative Launches to Transform the Non-Profit Sector Today marks a significant milestone with the launch of the Impact Collaborative (IC), a pioneering initiative aimed at revolutionizing the support provided to under-resourced communities. This innovative approach seeks to disrupt generational poverty while offering much-needed access to mental health and...

Continue Reading
Synovus Financial Corp Declares Quarterly Dividends for Investors

Updated Category News Views 128

Synovus Financial Corp Declares Quarterly Dividends Synovus Financial Corp. (NYSE: SNV) has recently revealed the details of its latest quarterly dividends. The board of directors has approved significant payouts to its shareholders, reinforcing the company’s ongoing commitment to deliver value to its investors. Details of the Declared Dividends The following dividends...

Continue Reading
Walnut Hill Medical Enhances Patient Access Through FDA TAP Program

Updated Category News Views 171

Walnut Hill Medical Partners with FDA in TAP Program Walnut Hill Medical, a prominent healthcare consultancy known for its market access and reimbursement strategies, has been chosen as an advisor to the FDA's Total Product Life Cycle Advisory Program (TAP). This initiative, which originated from the FDA's Center for Devices and Radiological Health (CDRH), aims to improve...

Continue Reading